Wednesday, February, 20, 2019 11:57:12

AstraZeneca inks deal with Sobi to sell the US rights for Synagis®

AstraZeneca, the pharmaceutical firm headquartered in Cambridge, has confirmed the sale of the U.S. rights to Synagis®, which is used for preventing respiratory tract infections, to specialty biopharmaceutical company Sobi AB. The multibillion-dollar deal would also involve nearly 130 workers being transferred to the Swedish …

Cisco to offer enhanced integrated SD-WAN security & cloud services

Globally renowned network hardware provider, Cisco Systems, Inc., in a bid to offer its customers enhanced IT service, plans to integrate its SD-WAN (software-defined wide-area networking) software with security features while improving support for cloud services. As per Ramesh Prabagaran, Cisco’s Senior Director of Product …